Did my vaccine work? New rapid test for the determination of vaccination success.
Am I really protected against the coronavirus now? This is a question asked by many after receiving a vaccination. The medtech company nal von minden from Moers in Germany has now developed a rapid test that can reliably detect antibodies against COVID-19 pathogens in blood. The NADAL® COVID-19 S1-NAb Test is now available all over Europe.
“People want clarity once they been vaccinated against coronavirus: They want to know if it has worked“ says Thomas Zander, CEO of nal von minden GmbH. Depending on the particular vaccine used, the COVID-19 vaccines offer 70% or more protection from the disease – but not 100%.
If the vaccine has ‘worked’, the body produces human antibodies against the disease. “These antibodies ensure that, in the event of exposure, the disease pathogens – the coronaviruses – would be readily identified and quickly repelled. Rather like the police on alert.”
These antibodies can be found in human blood and, if present, are easily detectable. With the NADAL® COVID-19 S1-NAb Test, the process takes just a few minutes. Thomas Zander explains: “Our new rapid test for the detection of coronavirus antibodies can be carried out by your GP in the future, as the test is currently only for professional use. A tiny prick of the finger is enough. The little drop of blood is added to the accompanying test cassette, and results can be read within 15 minutes.”
The new rapid test has already been comprehensively studied in the USA and China. “In the USA and China the vaccination programmes are more progressed, so the first studies were carried out there,” says Zander. “Further quality studies at German research centres will follow shortly.” It has been confirmed that the antibody test works for all kinds of vaccines (BioNtech, AstraZeneca, Johnson&Johnson, Sinovac and Moderna).
Coronavirus vaccinations usually take place across two appointments, and the new rapid test can be carried out either two weeks after the first vaccination, or two weeks after the second, says Thomas Zander. “Those who produce an immune response following the first vaccine – which can cause, for example, mild cold-like symptoms – can first wait until after the second vaccination.” Of course, the test can also be carried out weeks or even months afterwards, as nobody yet knows how long the vaccinations protect us against coronaviruses.
Press contact: Gabriele Hellwig, email@example.com
About nal von minden GmbH
Subscribe to releases from nal von minden GmbH
Subscribe to all the latest releases from nal von minden GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from nal von minden GmbH
COVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease.7.1.2021 12:10:24 CET | Pressmeddelande
Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes.
Corona rapid test: Celebrate Christmas together without anyone getting infected15.12.2020 13:57:54 CET | Press release
In many places, uncertainty is now mixed in with the anticipation of Christmas: will Christmas be a “super spreader event” as many politicians are warning? “No”, Roland Meissner, the CEO of nal von minden in Moers, Germany is convinced: “you can protect your relatives as best as possible by getting tested for corona beforehand.” There are also tips to minimize the risk of corona during the actual festivities.
nal von minden plans to produce 80 million rapid corona tests per month20.11.2020 11:43:34 CET | Pressmeddelande
Rapid corona testing is playing an increasingly important role in containing the pandemic everywhere – even though the first vaccines are now in sight. The medical technology company nal von minden GmbH from Moers, Germany, is therefore doubling its production: 40 million rapid antigen tests are already being produced in November. By January, this figure is expected to rise to 80 million – every month!
Combined rapid test for Covid-19 and influenza2.11.2020 09:00:00 CET | Pressmeddelande
Corona numbers are rising, and the next challenge is already in sight: Flu season is beginning. The symptoms can be very similar, but a test can differentiate between influenza and Covid-19.A new combined rapid test can detect coronavirus and influenza viruses simultaneously: The NADAL® COVID-19 Ag+Influenza A/B Test from German medical technology company nal von minden delivers a reliable result in just 15 minutes.
New Covid-19 antigen test: Fast and reliable results in just 15 minutes23.10.2020 16:14:31 CEST | Pressmeddelande
Preventing further spread of the coronavirus and taking pressure off laboratories – it is possible with the NADAL® Covid-19 Antigen Test from Germany. Whether in schools, nursing homes, hospitals, companies, or at the airport or larger events: The result is available in just 15 minutes. The new rapid test from medical technology company nal von minden GmbH is already approved in Europe and is available immediately. The high quality has been repeatedly verified.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom